Venture capital (VC) fundraising was unprecedented in H1
2022. Despite a slowdown in H2, funds closed out the year
with nearly $22B to invest into healthcare companies,
second only to the record $28B raised in 2021…
Venture capital (VC) fundraising was unprecedented in H1
2022. Despite a slowdown in H2, funds closed out the year
with nearly $22B to invest into healthcare companies,
second only to the record $28B raised in 2021…